A Study to Evaluate Self-esteem and Relationships in Males With Erectile Dysfuntion

PHASE4CompletedINTERVENTIONAL
Enrollment

780

Participants

Timeline

Start Date

May 31, 2003

Study Completion Date

May 31, 2004

Conditions
Erectile Dysfunction
Interventions
DRUG

sildenafil

sildenafil 50 mg tablet by mouth 1 hour before sexual activity for 12 weeks; the dose could be increased to 100 mg or decreased to 25 mg.

DRUG

placebo

placebo tablet by mouth 1 hour before sexual activity for 12 weeks

Trial Locations (66)

10126

Pfizer Investigational Site, Torino

13915

Pfizer Investigational Site, Marseille

20110

Pfizer Investigational Site, Turku

21013

Pfizer Investigational Site, Gallarate (VA)

28007

Pfizer Investigational Site, Madrid

28041

Pfizer Investigational Site, Madrid

28046

Pfizer Investigational Site, Madrid

30029

Pfizer Investigational Site, Nîmes

31403

Pfizer Investigational Site, Toulouse

35128

Pfizer Investigational Site, Padua

41100

Pfizer Investigational Site, Modena

46009

Pfizer Investigational Site, Valencia

46010

Pfizer Investigational Site, Valencia

48903

Pfizer Investigational Site, Barakaldo

50009

Pfizer Investigational Site, Zaragoza

53100

Pfizer Investigational Site, Siena

63023

Pfizer Investigational Site, Clermont-Ferrand

69437

Pfizer Investigational Site, Lyon

70124

Pfizer Investigational Site, Bari

90100

Pfizer Investigational Site, Oulu

92200

Pfizer Investigational Site, Neuilly-sur-Seine

94275

Pfizer Investigational Site, LE Kremlin Bicentre

95124

Pfizer Investigational Site, Catania

105425

Pfizer Investigational Site, Moscow

117036

Pfizer Investigational Site, Moscow

121552

Pfizer Investigational Site, Moscow

123448

Pfizer Investigational Site, Moscow

125101

Pfizer Investigational Site, Moscow

125206

Pfizer Investigational Site, Moscow

127411

Pfizer Investigational Site, Moscow

193318

Pfizer Investigational Site, Saint Petersburg

197089

Pfizer Investigational Site, Saint Petersburg

344068

Pfizer Investigational Site, Rostov-on-Don

630003

Pfizer Investigational Site, Novosibirsk

630087

Pfizer Investigational Site, Novosibirsk

656099

Pfizer Investigational Site, Barnaul

Unknown

Pfizer Investigational Site, Tampere

Pfizer Investigational Site, Krakow

Pfizer Investigational Site, Lodz

Pfizer Investigational Site, Lublin

Pfizer Investigational Site, Olsztyn

Pfizer Investigational Site, Szczecin

Pfizer Investigational Site, Warsaw

Pfizer Investigational Site, Moscow

Pfizer Investigational Site, Nizhny Novgorod

Pfizer Investigational Site, Saint Petersburg

Pfizer Investigational Site, Yekaterinburg

Pfizer Investigational Site, South Yorkshire

Pfizer Investigational Site, Taunton

06002

Pfizer Investigational Site, Nice

00100

Pfizer Investigational Site, Roma

03550

Pfizer Investigational Site, San Juan

08036

Pfizer Investigational Site, Barcelona

374 35

Pfizer Investigational Site, Karlshamn

205 02

Pfizer Investigational Site, Malmo

541 30

Pfizer Investigational Site, Skövde

171 76

Pfizer Investigational Site, Stockholm

331 85

Pfizer Investigational Site, Värnamo

593 81

Pfizer Investigational Site, Västervik

LL18 5UJ

Pfizer Investigational Site, Bodelwyddan

DH1 2QP

Pfizer Investigational Site, Belmont

FY4 3AD

Pfizer Investigational Site, Blackpool

M41 0UH

Pfizer Investigational Site, Urmston

TW15 3EA

Pfizer Investigational Site, Ashford

WS14 9JL

Pfizer Investigational Site, Nr Lichfield

KT15 2BH

Pfizer Investigational Site, Addlestone

All Listed Sponsors
lead

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

INDUSTRY

NCT00648596 - A Study to Evaluate Self-esteem and Relationships in Males With Erectile Dysfuntion | Biotech Hunter | Biotech Hunter